| Value | ₹12.00 Cr |
|---|
NSE filing, NSE: FLUOROCHEM. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Fluorochemicals Ltd: key numbers
- Share price
- ₹4,267.10
- Market cap
- ₹46,874 Cr
- Revenue (annual)
- ₹4,996 Cr
- Net profit (annual)
- ₹577.4 Cr
- P/E (TTM)
- 76.2×Sector 34.1×
- Promoter holding
- 61.39%+0.00% QoQ
- FII holding
- 4.53%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Fluorochemicals Ltd
All →Gujarat Fluorochemicals Board Meeting Date
Gujarat Fluorochemicals scheduled a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after the results.
Gujarat Fluorochemicals Other Announcement
Gujarat Fluorochemicals filed its quarterly shareholding pattern for the period ending September 30, 2026. The filing notes share transmission following a promoter's demise.
Gujarat Fluorochemicals Annual General Meeting
Gujarat Fluorochemicals held its Eighth Annual General Meeting on September 24, 2026, where members adopted financial statements, approved dividend declarations, and ratified director appointments.
Gujarat Fluorochemicals Other Announcement
Gujarat Fluorochemicals Limited has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as per SEBI listing regulations.
Gujarat Fluorochemicals Annual Report
Gujarat Fluorochemicals Limited has filed its Integrated Annual Report for 2025-26. The document also notifies the eighth Annual General Meeting scheduled for September 24, 2026.
Gujarat Fluorochemicals Dividend
Gujarat Fluorochemicals fixed 17th September 2026 as the Record Date for a final dividend of Rs. 3.00 per equity share for FY 2025-26.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr